GLOMTHERA
Live / Applied — New application — not yet assigned to an examiner (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 09 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79445697
- Mark type
- Stylized text
- Filed
- 09 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations and substances for the prevention, diagnosis and treatment of kidney diseases; reagents for use in medical genetic testing; biological, chemical and biochemical reagents for medical use; gene therapy products for medical and veterinary use; medical and veterinary preparations containing therapeutic DNA and RNA; biological, chemical, and biochemical reagents for medical purposes; pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, including, gene therapies, viral vectors, and nucleic-acid delivery products for use in the treatment of kidney diseases and disorders; pharmaceutical preparations for use in gene therapy; viral vectors for use in the delivery of gene therapy; adeno-associated virus (AAV) gene therapy; drug delivery agents consisting of capsids that facilitate delivery of pharmaceuticals and biopharmaceuticals; vaccines.
- Class 042 — Scientific and technological services: Pharmaceutical, medical and scientific research; providing scientific research information; research in the field of gene therapy; services for assessing the efficiency of pharmaceutical and medical preparations and substances; clinical trials; pharmaceutical and biopharmaceutical drug development services; research, and development of pharmaceutical preparations for gene therapy; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development regarding the use of screening platforms to discover, research and develop novel capsids for genetic delivery of gene therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery; providing medical and scientific research information on the prevention, diagnosis, and treatment of kidney diseases; providing a website featuring medical information and medical research; platform as a service (PaaS) featuring computer software platforms in the field of drug discovery and drug development.
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical and medical services; medical diagnostic and screening services; health care services; advisory services in the fields of medicine and pharmacology; consultancy and information services relating to pharmaceutical and medical preparations and substances; medical diagnosis and treatment of kidney diseases; medical testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of kidney diseases; pharmaceutical and medical information.
Owner
Prosecution history
- 15 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 15 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Mar 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB